Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.59 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.59 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.56 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.56 |
| ▸ | P2RX2 | Q9UBL9 | 3/20 | 0.56 |
| ▸ | DTYMK | P23919 | 2/20 | 0.54 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.53 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.53 |
| ▸ | SRC | P12931 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.53 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1763078 | 1.00 | POLB (0.65) | POLBP2RY1ENPP1P2RX3P2RX1 | |
| SCHEMBL29465233 | 1.00 | POLB (0.65) | POLBP2RY1ENPP1P2RX3P2RX1 | |
| SCHEMBL2508646 | 0.99 | POLB (0.66) | POLBP2RY1ENPP1P2RX3P2RX1 | |
| SCHEMBL2508660 | 0.99 | POLB (0.66) | POLBP2RY1ENPP1P2RX3P2RX1 | |
| SCHEMBL1533828 | 0.91 | POLB (0.65) | POLBP2RY1ENPP1P2RY2SRC | |
| SCHEMBL1533826 | 0.91 | POLB (0.65) | POLBP2RY1ENPP1P2RY2SRC | |
| SCHEMBL20266303 | 0.90 | POLB (0.64) | POLBP2RY1ENPP1P2RY2SRC | |
| SCHEMBL12932282 | 0.90 | POLB (0.64) | POLBP2RY1ENPP1P2RX3P2RX1 | |
| SCHEMBL12943893 | 0.90 | POLB (0.62) | POLBP2RY1ENPP1P2RX3P2RX1 | |
| SCHEMBL14471000 | 0.90 | POLB (0.80) | POLBP2RY1ENPP1P2RX3P2RX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 812 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250290128-A1 | METHOD OF MEASURING MICROSATELLITE LENGTH VARIATIONS | COLD SPRING HARBOR LABORATORY (US) | 2025-09-18 | — | — | US | claimed |
| US-20250210148-A1 | METHOD OF PRODUCING DATA-ENCODED NUCLEIC ACID AND NUCLEIC ACID PRODUCED BY THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-06-26 | — | — | US | claimed |
| CN-120064427-A | Method and analysis system for detecting brain nucleic acid hydrolysate spatial distribution based on mass spectrum imaging | 北京脑科学与类脑研究所 | 2025-05-30 | — | — | CN | claimed |
| CN-119913238-A | Compositions and methods for on-the-fly nucleic acid detection | 武汉大学 | 2025-05-02 | — | — | CN | claimed |
| CN-119286993-A | Compositions and methods for on-the-fly nucleic acid detection | 武汉大学 | 2025-01-10 | — | — | CN | claimed |
| CN-119220621-A | Method for removing non-target nucleic acid template | 南京诺唯赞生物科技股份有限公司 | 2024-12-31 | — | — | CN | claimed |
| US-20240384261-A1 | METHODS, COMPOSITIONS, AND KITS FOR PREPARING SEQUENCING LIBRARY | GENEFIRST LIMITED (GB) | 2024-11-21 | — | — | US | claimed |
| WO-2024222446-A1 | METHOD FOR REMOVING NON-TARGET NUCLEIC ACID TEMPLATE | 南京诺唯赞生物科技股份有限公司 | 2024-10-31 | — | — | WO | claimed |
| CN-115335536-B | Compositions and methods for on-the-fly nucleic acid detection | 武汉大学 | 2024-09-20 | — | — | CN | claimed |
| US-20240287594-A1 | COMPOSITIONS AND METHODS FOR ENRICHMENT OF NUCLEIC ACIDS USING LIGHT-MEDIATED CROSS-LINKING | DANA-FARBER CANCER INSTITUTE, INC. | 2024-08-29 | — | — | US | claimed |
| EP-0840803-A1 | SIMULTANEOUS SEQUENCING OF TAGGED POLYNUCLEOTIDES | LYNX THERAPEUTICS, INC. (US) | 1998-05-13 | — | — | EP | claimed |
| US-5691141-A | SOLID PHASE SYNTHESIS, LINKING LARGE MOLECULES TO NUCLEOTIDES TO DIFFERENTIATE | SEQUENOM, INC. (US) | 1997-11-25 | — | — | US | claimed |
| WO-1997032999-A1 | SIMULTANEOUS SEQUENCING OF TAGGED POLYNUCLEOTIDES | LYNX THERAPEUTICS, INC. (US) | 1997-09-12 | — | — | WO | claimed |
| WO-1997012061-A1 | METHOD FOR CHARACTERIZING NUCLEIC ACID MOLECULES | EPICENTRE TECHNOLOGIES CORPORATION (US) | 1997-04-03 | — | — | WO | claimed |
| US-5547835-A | USING THE SANGER SEQUENCING STRATEGY AND ASSEMBLING THE SEQUENCE INFORMATION BY ANALYSIS OF THE NESTED FRAGMENTS OBTAINED BY BASE-SPECIFIC CHAIN TERMINATION VIA THEIR DIFFERENT MOLECULAR MASSES | SEQUENOM, INC. (US) | 1996-08-20 | — | — | US | claimed |
| EP-0679196-A1 | DNA SEQUENCING BY MASS SPECTROMETRY | SEQUENOM, INC. (US) | 1995-11-02 | — | — | EP | claimed |
| WO-1994016101-A2 | DNA SEQUENCING BY MASS SPECTROMETRY | KOESTER HUBERT (US) | 1994-07-21 | — | — | WO | claimed |
| EP-0540693-A1 | THE REDUCTION OF NON-SPECIFIC AMPLIFICATION DURING $i(IN VITRO) NUCLEIC ACID AMPLIFICATION USING MODIFIED NUCLEIC ACID BASES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1993-05-12 | — | — | EP | claimed |
| WO-1992001814-A2 | THE REDUCTION OF NON-SPECIFIC AMPLIFICATION DURING IN VITRO NUCLEIC ACID AMPLIFICATION USING MODIFIED NUCLEIC ACID BASES | F. HOFFMANN-LA-ROCHE AG (CH) | 1992-02-06 | — | — | WO | claimed |
| US-4994372-A | Processive DNA polymerases | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1991-02-19 | — | — | US | claimed |